The Biggest Loser With Johnson & Johnson's COVID Vaccine Manufacturing Woes

Although Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine is no longer on pause, the healthcare giant still faces some major production challenges. In this Motley Fool Live video recorded on April 21, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the biggest loser with J&J's COVID-19 vaccine manufacturing woes.

Continue reading

Source Fool.com